• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY S ANTI-HCV REAGENT KIT; HEPATITIS C VIRUS ENCODED ANTIGENS (RECOMBINANT C100-3, HCR43)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY S ANTI-HCV REAGENT KIT; HEPATITIS C VIRUS ENCODED ANTIGENS (RECOMBINANT C100-3, HCR43) Back to Search Results
Catalog Number 06P04-55
Device Problem False Positive Result (1227)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/21/2020
Event Type  malfunction  
Manufacturer Narrative
(b)(6).An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6p04-55 that has a similar product distributed in the us, list number 6p04-60.
 
Event Description
The customer observed false reactive alinity s (b)(6) results on one donor specimen sid (b)(6) ran after known reactive donor specimen sid (b)(6).The results provided were: different specimen type results provided as below for that donor.(b)(6).There was no reported impact to patient management.
 
Manufacturer Narrative
The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Device history record review did not identify any non-conformances or deviations with the complaint lot and complaint issue.The alinity s anti-hcv test results for the serum sample (repeat reactive) align with the reference laboratory test results (positive for anti-hcv and hcv nat).Further, a review of the results data by engineering demonstrated that there is no evidence of potential sample contamination attributable to the instrument.A review of the product labeling concluded that the issue is sufficiently addressed.Based on our investigation, we have determined that there is no a systemic issue and/or product deficiency with alinity s anti-hcv lot number 16534be00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY S ANTI-HCV REAGENT KIT
Type of Device
HEPATITIS C VIRUS ENCODED ANTIGENS (RECOMBINANT C100-3, HCR43)
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key11131844
MDR Text Key255330665
Report Number3002809144-2021-00012
Device Sequence Number1
Product Code QHM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/05/2021
Device Catalogue Number06P04-55
Device Lot Number16534BE00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/18/2020
Initial Date FDA Received01/07/2021
Supplement Dates Manufacturer Received01/22/2021
Supplement Dates FDA Received01/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALNTY S SYSTEM, 06P16-01, (B)(4); ALNTY S SYSTEM, 06P16-01, (B)(4)
-
-